← All companies

OCGN

Ocugen, Inc.

OCGN Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.25

-0.01 -0.79%

Key statistics

from XBRL data in SEC filings

Market cap

$423M

Revenue (TTM)

$4.46M

Net income (TTM)

-$71.8M

EPS (TTM)

$-0.26

P/E ratio

—

Dividend yield

—

Free cash flow

-$57.1M

Cash

$31.9M

Total assets

$56.9M

Gross margin

—

52-week range

$0.93 – $2.73

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 13, 2026 8-K Shareholder vote results; Other events Jun 11, 2026 8-K Director or officer change Jun 3, 2026 8-K Director or officer change; Other events May 14, 2026 8-K Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure May 14, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity May 7, 2026 8-K Results of operations (earnings release); Other events May 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 4, 2026 8-K Regulation FD disclosure Mar 27, 2026 8-K Regulation FD disclosure Mar 24, 2026 8-K Other events Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Other events Mar 4, 2026 8-K Results of operations (earnings release) Mar 4, 2026 8-K Director or officer change Feb 9, 2026 8-K Regulation FD disclosure; Other events Jan 23, 2026 8-K Entered a material agreement; Other events Jan 21, 2026 8-K Other events Jan 15, 2026 8-K Director or officer change Dec 18, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Terminated a material agreement Sep 18, 2025 8-K Entered a material agreement Sep 16, 2025 8-K Entered a material agreement Sep 5, 2025 8-K Entered a material agreement; Regulation FD disclosure Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release) Aug 1, 2025 8-K Other events Jul 30, 2025 8-K Other events Jul 29, 2025 8-K Delisting notice or listing-rule failure Jul 1, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 23, 2025 8-K Other events Jun 17, 2025 8-K Shareholder vote results; Other events Jun 5, 2025 8-K Results of operations (earnings release) May 9, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Regulation FD disclosure May 1, 2025 8-K Director or officer change Apr 25, 2025 8-K Other events Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025